Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-31 @ 11:13 AM
Study NCT ID:
NCT01325194
Status:
COMPLETED
Last Update Posted:
2020-03-03
First Post:
2011-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis
Sponsor:
Nordic Lymphoma Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
NLG-LBC-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None